BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 6539309)

  • 1. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
    Haimanot RT; Mshana RN; McDougall AC; Andersen JG
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muramidase (lysozyme) findings in sural and radial nerve biopsies in leprosy patients after varying periods of treatment.
    Haimanot RT; McDougall AC; Mshana RN; Andersen JG; Belehu A
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):238-46. PubMed ID: 4020211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sural nerve biopsy findings in leprosy: a qualitative and quantitative light and electron microscope study in 4 treated cases of the lepromatous spectrum.
    Gibbels E; Behse F; Klingmüller G; Henke-Lübke U; Haupt WF; Gollmer E
    Clin Neuropathol; 1988; 7(3):120-30. PubMed ID: 3203481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
    Costa MB; Cavalcanti Neto PF; Martelli CM; Stefani MM; Maceira JP; Gomes MK; Schettini AP; Rebello PF; Pignataro PE; Ueda ES; Narahashi K; Scollard DM
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):177-86. PubMed ID: 11875761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light and electron microscopic study of peripheral nerve damage in patients with lepromatous leprosy (LL) and borderline lepromatous leprosy (BL).
    Kajihara H; Paturusi IA; Saleh RM; Rasyad C; Ikuta Y
    Hiroshima J Med Sci; 2000 Mar; 49(1):83-92. PubMed ID: 10824461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural pathology in leprosy during treatment and surveillance.
    Porichha D; Mukherjee A; Ramu G
    Lepr Rev; 2004 Sep; 75(3):233-41. PubMed ID: 15508900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal mucosa and skin of smear-positive leprosy patients after 24 months of fixed duration MDT: histopathological and microbiological study.
    Ebenezer GJ; Job A; Abraham S; Arunthathi S; Rao PS; Job CK
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):292-7. PubMed ID: 10575409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of changes in the nasal mucosa in indeterminate, tuberculoid and borderline leprosy.
    Chacko CJ; Bhanu T; Victor V; Alexander R; Taylor PM; Job CK
    Lepr India; 1979 Jan; 51(1):8-22. PubMed ID: 376945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
    Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histopathology of lepromatous leprosy in the nose.
    McDougall AC; Rees RJ; Weddell AG; Kanan MW
    J Pathol; 1975 Apr; 115(4):215-26. PubMed ID: 1099180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological study of apparently normal skin of patients with leprosy.
    El-Darouti MA; Hussein S; Marzouk SA; Nabil N; Hunter NS; Mahgoub D; El-Eishi NH; Abdel-Halim MR
    Int J Dermatol; 2006 Mar; 45(3):292-6. PubMed ID: 16533232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hansen's disease: case report and review of literature].
    Concha R M; Cossio T ML; Salazar S I; Fich S F; Pérez C C; González B S
    Rev Chilena Infectol; 2008 Feb; 25(1):64-9. PubMed ID: 18273528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viability of Mycobacterium leprae in lepromatous patients after five years of dapsone monotherapy supplemented with two years of multidrug therapy.
    Sivaprasad N; Snehalatha S; Lobo D; Aschhoff M; Job CK
    Indian J Lepr; 1995; 67(4):427-33. PubMed ID: 8849919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two multidrug fixed-dosage treatment regimens with multibacillary leprosy patients.
    Gallo ME; Alvim MF; Nery JA; Albuquerque EC; Sarno EN
    Indian J Lepr; 1996; 68(3):235-45. PubMed ID: 8889609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.